His experience of having worked as both outside and in-house counsel enables Bret to be highly cognizant of the challenges that his clients face in creating and managing their intellectual property portfolios. Being a member of the Board of Directors for an emerging consumer product and health care corporation affords him unique insight into how intellectual property strategically impacts a company’s business plan and overall valuation. Several of the patents that Bret has obtained for his clients have been litigated, giving him the experience needed to obtain enforceable proprietary rights for his clients.
Bret’s clients look to him for advice regarding a diverse array of technologies, including biotechnology, drug delivery systems, medical devices, analytical devices, diagnostics and chemistry. He assists his clients in patent procurement, freedom to operate and intellectual property due diligence analyses, and trademark registration.
Bret received an A.B. in Biochemistry from Dartmouth College in 1989 and a J.D. from the University of California, Hastings College of the Law in 1992.
His expertise in the intellectual property development and procurement process has led him to be invited to speak at Stanford University on topics such as intellectual property and obtaining patents for start-ups.